Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014

Annals of Surgical Oncology
Christer GroebenJohannes Huber

Abstract

Our aim was to assess and compare trends of urinary diversion (UD) for patients receiving radical cystectomy for the treatment of bladder cancer in the US and Germany, and to investigate decisive predictors for the choice of UD. We analyzed the nationwide German hospital billing database and the Nationwide Inpatient Sample (NIS) from 2006 to 2014. Cases with a bladder cancer diagnosis combined with RC were included, and trends in the choice of UD, transfusion rates, length of stay, and mortality were assessed. From 2006 to 2014, the total number of RCs recorded within the NIS were 17,711, with a varying annual caseload of 1666-2009, while RC numbers increased from 5627 to 7390 in Germany (p < 0.001 for trends), with a total of 60,447 cases. The share of incontinent UD in the US remained stable at 93%, while increasing from 63.2 to 70.8% in Germany. Multivariate models indicated age and sex were the most important factors associated with the choice of UD in both countries, while hospital caseload and teaching status were less relevant factors in the US. In-hospital mortality was lower in the US compared with Germany (1.9% vs. 4.6%; p < 0.001), with significantly shorter hospital stays (10.7 days in the US vs. 25.1 days in German...Continue Reading

References

Aug 15, 2006·European Urology·Vladimir NovotnyManfred P Wirth
May 8, 2007·Urology·Brent K HollenbeckJohn D Birkmeyer
Nov 21, 2008·World Journal of Urology·John L GoreUNKNOWN Urologic Diseases in America Project
Jun 2, 2009·European Urology·Michael FroehnerUrs E Studer
Nov 20, 2009·Cancer·John L GoreUNKNOWN Urologic Diseases in America Project
May 4, 2012·BJU International·David HorovitzAlexandre R Zlotta
Sep 22, 2012·European Urology·Richard E HautmannUNKNOWN International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012
Oct 25, 2012·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Marco BianchiPierre I Karakiewicz
Jan 1, 2012·Materia Socio-medica·Goran RidicOgnjen Ridic
Aug 3, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Florian RoghmannJüri Palisaar
Sep 27, 2013·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Florian RoghmannMaxine Sun
Jan 7, 2014·European Urology·Atiqullah AzizUNKNOWN PROMETRICS 2011 research group
Mar 17, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Benjamin HagerJohannes Huber
Aug 19, 2015·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Brian J MinnilloRobert Abouassaly
Oct 7, 2015·PLoS Medicine·Eric I BenchimolUNKNOWN RECORD Working Committee
Aug 24, 2016·Prostate Cancer and Prostatic Diseases·C GroebenJ Huber
Aug 15, 2017·European Urology·Jeffrey J LeowQuoc-Dien Trinh

❮ Previous
Next ❯

Citations

Jul 20, 2018·Annals of Surgical Oncology·Richard Hautmann, Christian Bolenz
Mar 7, 2020·Current Opinion in Urology·Nima Almassi, Bernard H Bochner
Apr 17, 2019·ANZ Journal of Surgery·Oliver Best, Manish I Patel
May 19, 2021·The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS·Pengchao WangXu Zhang
Sep 16, 2021·Der Urologe. Ausg. A·Markus MaierJohannes Huber
Jun 28, 2021·Current Opinion in Urology·Guus W B JanssenAntoine G van der Heijden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.